Phil Whittaker

Nick Dearden, author of PharmaNomics, and Phil Whitaker, a seasoned NHS GP, dive into the murky waters of Big Pharma's influence on healthcare. They discuss how pharmaceutical companies have historically manipulated doctors and the regulatory environment to prioritize profits. The dark legacy of OxyContin marketing reveals the dangerous consequences of profit-driven strategies. Dearden and Whitaker also advocate for rethinking pharmaceutical regulations, emphasizing the need for public interest over corporate profit, inspired by innovative models from countries like South Africa.

Will Dunn, Business editor for The New Statesman, dissects Keir Starmer's ambitious pledge to raise defense spending, revealing the tangled math behind these budget promises. Phil Whittaker, GP and health writer, reflects on the upheaval in NHS leadership, particularly following Amanda Pritchard’s resignation. They delve into the urgent reforms needed in the healthcare system, while exploring how increased defense budgets could clash with domestic needs. This lively discussion unpacks the critical interplay between national security and public health.